CCM
ASTX

Cadence Capital Management’s ASTEX PHARMACEUTICALS, INC COM ASTX Stock Holding History

Cadence Capital Management’s Portfolio ASTX Stock Details ASTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-43,990
Closed -$373K – 697
2013
Q3 		$373K Buy
+43,990
New +$278K 0.01% 559

Cadence Capital Management's ASTX Position: Q4 2013 in Review

Cadence Capital Management sold out of ASTEX PHARMACEUTICALS, INC COM (ASTX) in Q4 2013, closing a stake of 43,990 shares — an estimated $373K sold.

Cadence Capital Management first reported a position in ASTX in Q3 2013 and held it in 1 quarter. The position peaked at $373K in Q3 2013. 0 funds tracked by Wall St. Rank hold ASTX as of Q4 2013.

  • Cadence Capital Management reported no remaining ASTEX PHARMACEUTICALS, INC COM position as of Q4 2013 after selling out during the quarter.
  • Cadence Capital Management sold 43,990 ASTEX PHARMACEUTICALS, INC COM shares in Q4 2013, an estimated $373K.
  • Cadence Capital Management first reported a position in ASTEX PHARMACEUTICALS, INC COM in Q3 2013 and held it in 1 quarter.
  • Cadence Capital Management's ASTEX PHARMACEUTICALS, INC COM position peaked at $373K in Q3 2013.
  • 0 funds tracked by Wall St. Rank held ASTEX PHARMACEUTICALS, INC COM as of Q4 2013.

Based on Cadence Capital Management's 13F filing for Q4 2013, filed 31 Jan 2014.